Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder

In this case-control study of 34?505 Medicare beneficiaries, patients had greater risk of experiencing an opioid overdose and had higher health care expenditures in buprenorphine treatment gap months compared with treated months.